Significantly, administration of the FASN inhibitor orlistat or cetuximab alone impeded the tumor volume and tumor mass of CSN6-high PDXs with some efficacy, while a combination of these two drugs was more efficient in suppressing tumor growth (Fig. 8f, g). This evidence concerns the gene FASN and neoplasm.